论文部分内容阅读
目的 :本文就甲基强的松龙治疗重症哮喘并发呼吸衰竭的临床效果进行研究及探讨。方法 :选取我院在近一年收治的96例重症哮喘并发呼吸衰竭患者,按照入院先后顺序分为两个组别,实验组与参照组各48例。对参照组患者予以常规治疗法,对实验组患者加用甲基强的松龙治疗,将两组患者的治疗总有效率、肺功能指标改善程度进行比对。结果 :实验组患者的治疗总有效率高于参照组,PEF、FVC以及FEV1各项指标的改善程度均优于参照组,P<0.05。结论 :在重症哮喘合并呼吸衰竭的临床治疗中,加用甲基强的松龙具有理想效果,对减轻患者症状、改善肺功能均有积极作用,值得推广。
Objective: In this paper, methylprednisolone treatment of severe asthma complicated with respiratory failure clinical research and discussion. Methods: A total of 96 patients with severe asthma complicated with respiratory failure admitted to our hospital in recent one year were divided into two groups according to the order of admission, and 48 patients in experimental group and reference group. The patients in the reference group were given conventional therapy, and the patients in the experimental group were treated with methylprednisolone. The total effective rate of treatment and the improvement of lung function index were compared between the two groups. Results: The total effective rate of the experimental group was higher than that of the reference group, PEF, FVC and FEV1 indicators improved better than the reference group, P <0.05. Conclusion: In the clinical treatment of severe asthma with respiratory failure, the application of methylprednisolone has the ideal effect, which has a positive effect on alleviating the symptoms of patients and improving lung function, and is worth promoting.